Bharat Immunologicals Cash and Equivalents

BIBCL -- India Stock  

INR 20.40  1.55  8.22%

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools
Symbol
Refresh

Cash and Equivalents Analysis

Cash or Cash Equivalents are the most liquid of all assets found on company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Bharat Immunologicals 
Cash 
 = 
Bank Deposits 
+  
Liquidities 
 = 
235.01 M

About Cash and Equivalents

Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually 3 months).
Compare to competition
In accordance with recently published financial statements Bharat Immunologicals Biologicals Corp Ltd has 235.01 M in Cash and Equivalents. This is much higher than that of the Healthcare sector, and significantly higher than that of Cash and Equivalents industry, The Cash and Equivalents for all stocks is over 1000% lower than the firm.

Peer Comparison

Bharat Immunologicals Cash and Equivalents Comparison
Bharat Immunologicals is currently under evaluation in cash and equivalents category among related companies.

Did you try this?

Run Risk-Return Analysis Now
   

Risk-Return Analysis

View associations between returns expected from investment and the risk you assume
All  Next Launch Risk-Return Analysis

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Fundamental Indicators

Current Bharat Immunologicals financial ratios